Henoch-Schönlein purpura medical therapy

Henoch-Schönlein purpura Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Henoch-Schönlein purpura from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Henoch-Schönlein purpura medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Henoch-Schönlein purpura medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Henoch-Schönlein purpura medical therapy
CDC on Henoch-Schönlein purpura medical therapy
Henoch-Schönlein purpura medical therapy in the news
Blogs on Henoch-Schönlein purpura medical therapy
Directions to Hospitals Treating Henoch-Schönlein purpura
Risk calculators and risk factors for Henoch-Schönlein purpura medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical therapy

Supportive Management

• Management of HSP is primarily supportive and includes
  • Adequate hydration
  • Monitoring renal complications by balancing fluid and electrolyte, and controlling hypertention.
• Symptoms such as arthritis, edema, fever are treated by acetaminophen, leg elevation, and adequate hydration.